-
Education is the foundation of quality improvement, which is why one IRB's main educational tool for investigators is an on-line form for quality improvement through self-assessment.
-
Biomonitoringmeasuring levels of environmental toxins in biological samples taken from volunteersis an important tool in public health research, providing valuable information about local exposure levels.
-
As research participants confront ever more-complicated clinical trials, they also encounter longer, more complex consent forms. Concerns that informed consent isn't necessarily enhanced by these documents has led researchers to seek more useful ways of educating subjects about the study they're considering.
-
Experienced and educated IRB professionals are in a very good position this year to command top salaries and find jobs in a variety of research settings, according to experts and the results of the 2007 salary survey conducted by IRB Advisor.
-
Quality improvement (QI) is such an important part of the daily work process at one independent, Midwestern IRB that there are 17 employees on the regulatory affairs and quality improvement team.
-
-
Poised to be one of the latest generation ventricular assist devices (VADs) to win FDA approval is the HeartMate II from Thoratec (Pleasanton, California). The company featured the device during the Scientific Sessions of the Heart Failure Society of America (St. Paul, Minnesota) by making available at its exhibit area two real-life case studies: two people implanted with the device.
-
Cardiovascular disease remains the No. 1 cause of death in Europe, making the market for products used in diagnosing, monitoring and treating heart disease and stroke one of the largest segments of the medical device market in the region.
-
As a result of safety issues with DES recently reinforced by the COURAGE study, and others, indicating that PCI/stenting may offer no greater length of life than medical therapy utilization has declined substantially, particularly in the U.S. where usage has slumped from 87% of procedures in 2005 to the current rate of 64%, according to cardiologists at the ESC congress.
-
The fifth annual Vascular Interventional Advances (VIVA) meeting took place in Las Vegas in late September, with that gathering seeking to integrate all four specialties involved in the care of patients with vascular disease: vascular surgery, interventional cardiology, vascular medicine and interventional radiology.
